These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25429655)

  • 1. Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.
    Zghair AN; Sharma R; Sharma AK
    Curr Pharm Biotechnol; 2014; 15(12):1113-24. PubMed ID: 25429655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insight of drug resistance with special focus on iron in estrogen receptor positive breast cancer.
    Mittal R; Chaudhry N; Pathania S; Mukherjee TK
    Curr Pharm Biotechnol; 2014; 15(12):1141-57. PubMed ID: 25429654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?
    Wang L; Di LJ
    Int J Biol Sci; 2014; 10(5):566-75. PubMed ID: 24910535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.
    Gorski JJ; Kennedy RD; Hosey AM; Harkin DP
    Clin Cancer Res; 2009 Mar; 15(5):1514-8. PubMed ID: 19223511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
    Lee EY
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].
    Pujol P; This P; Noruzinia M; Stoppa-Lyonnet D; Maudelonde T
    Bull Cancer; 2004; 91(7-8):583-91. PubMed ID: 15381448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and BRCA1 deficiency synergistically induce breast cancer mutation-related DNA damage.
    Chen J; Liu J; Zeng P; Zhao C; Liu X; Sun J; Wang J; Fang P; Chen W; Ding J
    Biochem Biophys Res Commun; 2022 Jul; 613():140-145. PubMed ID: 35561581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1, hormone, and tissue-specific tumor suppression.
    Hu Y
    Int J Biol Sci; 2009; 5(1):20-7. PubMed ID: 19119312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
    Foulkes WD; Goffin J; Brunet JS; Bégin LR; Wong N; Chappuis PO
    J Natl Cancer Inst; 2002 Oct; 94(19):1504-6. PubMed ID: 12359859
    [No Abstract]   [Full Text] [Related]  

  • 12. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
    Calvo V; Beato M
    Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen.
    Spillman MA; Bowcock AM
    Oncogene; 1996 Oct; 13(8):1639-45. PubMed ID: 8895509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers.
    Lecarpentier J; Noguès C; Mouret-Fourme E; Buecher B; Gauthier-Villars M; Stoppa-Lyonnet D; Bonadona V; Fricker JP; Berthet P; Caron O; Coupier I; Pujol P; Faivre L; Gesta P; Eisinger F; Mari V; Gladieff L; Lortholary A; Luporsi E; Leroux D; Venat-Bouvet L; Maugard CM; Colas C; Tinat J; Lasset C; Andrieu N;
    Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):698-707. PubMed ID: 25613119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent?
    Noruzinia M; Coupier I; Pujol P
    Cancer; 2005 Oct; 104(8):1567-74. PubMed ID: 16155942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.
    de la Cruz J; Andre F; Harrell RK; Bassett RL; Arun B; Mathieu MC; Delaloge S; Gilcrease MZ
    Hum Pathol; 2012 Nov; 43(11):1932-9. PubMed ID: 22591913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
    Lusa L; Peissel B; Manoukian S; Marchesi E; Radice P; Pierotti MA; Gariboldi M
    J Natl Cancer Inst; 2008 May; 100(10):752-3; author reply 753-4. PubMed ID: 18477803
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
    Heublein S; Mayr D; Meindl A; Angele M; Gallwas J; Jeschke U; Ditsch N
    PLoS One; 2015; 10(6):e0127072. PubMed ID: 26029931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.